Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JEVAX
- Development stage
- Unknown
- Lead developer
- Vabiotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
JEVAX is an inactivated, mouse brain-derived Japanese encephalitis vaccine developed by the Company for Vaccine and Biological Production No.1 (VABIOTECH) in collaboration with the National Institute of Hygiene and Epidemiology (NIHE) in Vietnam. Utilizing the Nakayama strain of the Japanese encephalitis virus, the vaccine was developed with technology transfer from Japan and the World Health Organization (WHO) starting in 1989. It was officially integrated into Vietnam's national Extended Program of Immunizations (EPI) in 1997. JEVAX is administered subcutaneously, typically in a three-dose regimen for children aged 1 to 5 years, and has served as a standard control in clinical trials for newer generation Vero cell-derived Japanese encephalitis vaccines.
- Brand names
- JEVAX
- Other names
- Japanese encephalitis vaccine (mouse brain-derived)VABIOTECH Japanese encephalitis vaccine
02
Targets
E (Tick-borne encephalitis virus envelope protein)
Beyond the preview
Go deeper on JEVAX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JEVAX.